Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Amplex Red: Precision in Reactive Oxygen Species Detection A
2026-08-03
Amplex Red (10-Acetyl-3,7-dihydroxyphenoxazine) offers unmatched sensitivity for hydrogen peroxide and peroxidase detection in biochemical and cell-based workflows. This guide reveals how APExBIO’s reagent enables robust oxidative stress monitoring, highlights workflow optimizations, and translates new insights from ecosystem redox research into practical assay improvements.
-
Genistein: Cytoskeleton-Dependent Autophagy and Cancer Workf
2026-08-03
Genistein's dual role in protein tyrosine kinase inhibition and modulation of cytoskeleton-dependent autophagy enables unrivaled experimental flexibility in cancer and mechanotransduction research. This article translates the latest mechanistic insights into precise, actionable workflows for scientists investigating cell proliferation, apoptosis, and chemoprevention.
-
A20 Suppresses Oxidized Self-DNA Inflammation in AKI Models
2026-08-02
This study uncovers how the ubiquitin-editing enzyme A20 mitigates inflammation driven by oxidized self-DNA in acute kidney injury (AKI). By delineating the suppression of the NLRP3 inflammasome and cGAS-STING pathway, the research provides mechanistic insights into inflammation control in AKI and highlights new therapeutic strategies.
-
Cardiogreen (Indocyanine Green): Translational Leverage in D
2026-08-01
This thought-leadership article explores how Cardiogreen (Indocyanine Green) advances both precision diagnostics and immuno-oncology research. Bridging mechanistic insight from tumor biology to practical translational guidance, it highlights Cardiogreen's dual role as a vascular imaging dye and a potent photosensitizer for photodynamic therapy, contextualized within emerging immunotherapy strategies. The discussion critically integrates recent findings on photothermal therapy and tumor microenvironment modulation, offering actionable protocols and strategic recommendations for translational researchers.
-
Cy5 amine (non-sulfonated): Technical Guide for Biomolecule
2026-07-31
Cy5 amine (non-sulfonated) provides a bright, photostable, amine-functionalized cyanine dye for sensitive labeling of proteins, peptides, and polymers in non-aqueous or mixed-solvent workflows. It is not suitable for direct aqueous labeling or diagnostic/clinical applications, and requires rigorous solvent and protocol control for reproducible fluorescence detection.
-
Hydroxychloroquine Sulfate for Autoimmune Disease Research W
2026-07-31
Hydroxychloroquine Sulfate (SKU B4874) is designed for research applications targeting autophagy and toll-like receptor signaling in autoimmune disease models. It is optimized for aqueous-based, short-term workflows and is not compatible with protocols requiring organic solvents or long-term solution storage.
-
Actinomycin D in Cancer Research: Workflows, Assays & Troubl
2026-07-30
Actinomycin D (ActD) delivers precision transcriptional inhibition, enabling robust analysis of mRNA stability, DNA damage response, and apoptosis induction in cancer models. By leveraging validated protocols and troubleshooting strategies, researchers can maximize data fidelity and reproducibility in complex cellular assays.
-
GPR35-KLF5 Circuitry Decodes Damage Signals in Colitis Repai
2026-07-30
This study uncovers how intestinal epithelial cells use GPR35 to sense tryptophan metabolism perturbations and activate KLF5-driven repair programs via PI3K-AKT-mTOR signaling. The findings provide mechanistic insight into mucosal healing in ulcerative colitis and suggest new strategies for targeted intervention in intestinal inflammation models.
-
JNJ-26854165 (Serdemetan): Advanced Insights for p53 Modulat
2026-07-29
Explore the unique anti-proliferative and apoptosis-inducing properties of JNJ-26854165 (Serdemetan) in p53 wild-type cancer models. This in-depth analysis reveals new assay strategies and practical considerations for cancer research.
-
AIBP-LRP2–Mediated HDL Uptake Regulates Capillary Collateral
2026-07-29
The referenced study elucidates a mechanism by which AIBP-LRP2–mediated uptake of HDL-associated miR-223 restricts the expansion of CXCR4+ stemlike capillary endothelial cells (CECs), limiting collateral circulation. These findings provide a molecular framework for targeting vascular remodeling in ischemic disease and suggest new avenues for therapeutic intervention.
-
Auranofin: Applied Workflows for Thioredoxin Reductase Inhib
2026-07-28
Auranofin stands out as a precise thioredoxin reductase inhibitor, enabling robust experimental control over redox homeostasis and apoptosis. This guide provides actionable workflow enhancements, troubleshooting strategies, and contextualizes Auranofin's unique value in mechanotransduction and cancer research.
-
High-Throughput Target Deconvolution in Tuberculosis Drug Di
2026-07-28
Santa Maria et al. present a machine learning-driven framework linking phenotypic antibacterial screens to mechanism of action and target identification in Mycobacterium tuberculosis. Their integrative approach reveals novel dihydrofolate reductase inhibitors and provides a scalable model for rational antibiotic discovery.
-
Cabozantinib (XL184) in RCC: Protocol Advances & Phosphoprot
2026-07-27
Harness the multi-kinase blockade of Cabozantinib (XL184) for advanced renal cell carcinoma research. This article unpacks systems-level phosphoproteomic adaptation, optimized protocols, and practical troubleshooting—helping you transform complex kinase inhibitor data into robust, reproducible workflows.
-
AT13387: Hsp90 Inhibitor Workflows for Cancer Biology Resear
2026-07-27
AT13387 stands out as a potent, orally bioavailable Hsp90 inhibitor with distinct advantages for dissecting apoptosis and signal transduction in cancer biology research. This guide details optimized protocols, troubleshooting insights, and workflow enhancements that harness AT13387’s unique properties for reproducible and advanced experimental outcomes.
-
Bafilomycin A1: Precision V-ATPase Inhibitor in Cell Biology
2026-07-26
Bafilomycin A1 empowers researchers to dissect lysosomal acidification, autophagy, and metabolic adaptation with nanomolar precision. This guide translates new mechanistic insights and workflow optimizations into actionable protocols for cancer, osteoclast, and intracellular pH regulation studies.